Green tea extract can inhibit HIV rebound
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-06-28
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Green Tea Extract Approved as a Food Supplement Ingredient in Canada
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
McKinsey Pays to Close a Purdue Liability Chapter
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
Recommend Reading
-
Pfizer Sues Metsera and Novo Nordisk Over Rival Obesity Drug Strategy
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
Weak Consumption Leads to Decline in ABS Prices in Mid-May in China
-
The negative spread has widened, with acrylic acid prices continuously falling and showing weakness domestically in China
-
Supporting Easing This Week, Shandong Normal Butanol Market Weakly Operates
-
Polyester bottle chip prices showed overall volatility and weakness this week, with a slight rise followed by a decline within the week in China
-
Sodium Metabisulfite Prices Rise This Week in China (4.13-4.17)